Zur Startseite Zur Hauptnavigation Zum Inhalt Zum Kontakt Zur Sitemap
+A-
ENDE
  menu
Center for Sepsis Control and Care
  EMERGENCY
  menu
  • Sepsis
  • Research
    • Publications
    • Archive 2015-2020
    • Archive 2010-2015
      • Risk Assessment and Sepsis Control
      • Novel Diagnostic Tools and Approaches
      • Acute Care
      • Sepsis-related Organ Failure
        • PRAISE
        • HHDP
        • HIFMORG
        • SMAD2
        • Candida
        • SomatostatinR
        • PI3Kgamma
        • Rosisep
        • ADAMTS13
        • Thrombomodulin
        • Liver Dysfunction
        • Seda
        • Sephi
        • Phosphatidylcholine
        • MomCanSep
      • Long-term Sequelae
      • Overarching Projects
  • World Sepsis Day
  • Main menu
    • Patients & Relatives
    • Research
    • Teaching and study
    • Doctors & Referrers
    • Clinics & Institutes
    • Careers
    • University Hospital
  • Sepsis
  • Research
    • Publications
    • Archive 2015-2020
    • Archive 2010-2015
      • Risk Assessment and Sepsis Control
      • Novel Diagnostic Tools and Approaches
      • Acute Care
      • Sepsis-related Organ Failure
        • PRAISE
        • HHDP
        • HIFMORG
        • SMAD2
        • Candida
        • SomatostatinR
        • PI3Kgamma
        • Rosisep
        • ADAMTS13
        • Thrombomodulin
        • Liver Dysfunction
        • Seda
        • Sephi
        • Phosphatidylcholine
        • MomCanSep
      • Long-term Sequelae
      • Overarching Projects
  • World Sepsis Day
home / Research / Archive 2010-2015 / Sepsis-related Organ Failure / MomCanSep

Molecular Mechanisms of Candida Sepsis

 

Acronym: MomCanSep

Principal Investigator: Prof. Bernhard Hube

Team: Ilse Jacobsen, Betty Hebecker, Tony Pawlik, Nadja Jablonowski

Research Area: D Sepsis related Organ Failure

Project Number: D1.15

Duration: 01.08.2012 - 31.07.2015

Module: In-house Professorship Group


The aim of this project is to identify and characterize sepsis-associated fungal factors and their molecular interaction with host cells and thus to elucidate the molecular basis of Candida albicans sepsis


Project summary

Candida albicans is the most common cause of life-threatening nosocomial fungal infections. The mortality of sepsis caused by Candida is >50%,  higher than for bacterial septicaemias. During systemic infections, C. albicans can infect almost all organs, however, the host response and the ability to clear C. albicans cells is organ-specific. In the murine model of haematogenously disseminated candidiasis, which is the gold standard for investigating the pathogenesis of C. albicans bloodstream infections, mice die of progressive sepsis, kidney inflammation and failure, while fungal load declines in all other infected organs without causing pathological alterations. These data suggest that fungal pathogenicity is not only due to damage caused by the fungus, but also due to an inappropriate host response leading to damage caused by immune cells.

In this project, we aim to identify and characterise fungal factors which are responsible for the organ-specific host responses and the immunopathology in the kidneys. We propose that, (1) in addition to general cell wall components, distinct factors or activities are recognised and responsible for the differential host response and immunopathology; (2) fungal genes exist, which are not required for causing host damage, but for an organ-specific host response which is either protective or non-protective. We will use in vivo transcriptional profiling and large scale C. albicans mutant collection screening to identify such genes. Proof-of-principle candidate genes which have such characteristics have already been identified. These genes and their role during systemic C. albicans infection will be investigated in detail.

Therefore, this project aims at understanding the molecular mechanisms of sepsis induction triggered by C. albicans. The knowledge of the mechanisms responsible for sepsis caused by systemic candidiasis may provide potential targets for novel ways of immune therapy.


Work program

The work program comprises four main parts:

Part 1: Identification of stage-, tissue-, organ-, and infection-associated fungal genes potentially responsible for host responses

Part 2: Production of mutants lacking virulence associated genes and collection of large scale mutant libraries

Part 3: Large scale host response screening of mutant collections

Part 4: Detailed analysis of identified candidate genes for triggering sepsis


Vision

In this project, we aim at understanding the molecular mechanisms of sepsis induction triggered by C. albicans by identifying the fungal genes, factors or activities which are responsible for or contribute to the differential host responses in the different organs. Ultimately, the knowledge of the mechanisms responsible for sepsis caused by systemic candidiasis may provide potential targets for novel ways of immune therapy.


Selected publications

Seider K, Gerwien F, Kasper L, Allert S, Brunke S, Jablonowski N, Schwarzmüller T, Barz D, Rupp S, Kuchler K, Hube B (2014) Immune evasion, stress resistance, and efficient nutrient acquisition are crucial for intracellular survival of Candida glabrata within macrophages. Eukaryotic Cell 13:170-183

Brunke S, Hube B (2013) Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell Microbiol. 15(5):701-708

Lüttich A, Brunke S, Hube B, Jacobsen ID (2013) Serial passaging of Candida albicans in systemic murine infection suggests that the wild type strain SC5314 is well adapted to the murine kidney. PloS one 8: e64482

Martin R, Albrecht-Eckardt D, Brunke S, Hube B, Hünniger K, Kurzai O (2013) A Core Filamentation Response Network in Candida albicans Is Restricted to Eight Genes. PloS one 8: e58613

Mayer FL, Wilson D, Hube B (2013) Candida albicans pathogenicity mechanisms. Virulence 4: 119-128

Mayer FL, Wilson D, Hube B (2013) Hsp21 potentiates antifungal drug tolerance in Candida albicans. PloS one 8: e60417

Miramon P, Kasper L, Hube B (2013) Thriving within the host: Candida spp. interactions with phagocytic cells. Med Microbiol Immunol  202: 183-195

Pietrella D, Pandey N, Gabrielli E, Pericolini E, Perito S, Kasper L, Bistoni F, Cassone A, Hube B, Vecchiarelli A. (2013) Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome. Eur J Immunol. 43: 679-692

Citiulo F, Jacobsen ID, Miramon P, Schild L, Brunke S, Zipfel P, Brock M, Hube B, Wilson D (2012) Candida albicans scavenges host zinc via Pra1 during endothelial invasion. PLoS Pathog 8: e1002777 (→ Publication award of the DMyk)

Gow NA, Hube B (2012) Importance of the Candida albicans cell wall during commensalism and infection. Current Opinion in Microbiology 15: 406-412

Jacobsen ID, Wilson D, Wächtler B, Brunke S, Naglik JR, Hube B (2012) Candida albicans dimorphism as a therapeutic target. Expert Rev Anti Infect Ther. 10(1):85-93

Lüttich A, Brunke S, Hube B. (2012) Isolation and amplification of fungal RNA for microarray analysis from host samples. Methods Mol Biol. 845:411-21

Mayer FL, Wilson D, Jacobsen ID, Miramon P, Slesiona S, Bohovych IM, Brown AJ, Hube B (2012) Small but crucial: the novel small heat shock protein Hsp21 mediates stress adaptation and virulence in Candida albicans. PloS one 7: e38584

Miramón P, Dunker C, Windecker H, Bohovych IM, Brown AJ, Kurzai O, Hube B. (2012) Cellular Responses of Candida albicans to Phagocytosis and the Extracellular Activities of Neutrophils Are Critical to Counteract Carbohydrate Starvation, Oxidative and Nitrosative Stress. PLoS One. 7(12):e52850


Contact 

Prof. Bernhard Hube

Tel. + 49 (0)3641 - 532 1401 oder 00

Abteilung Mikrobielle Pathogenitätsmechanismen
Leibniz Institut für Naturstoff-Forschung und Infektionsbiologie e.V.
Hans-Knöll-Institut (HKI)
Beutenbergstraße 11a
07745 Jena

Website of the Department of Microbial Pathogenicity Mechanisms (MPM) at the HKI

Sepsis
Research
World Sepsis Day
Sitemap